These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 30683109)

  • 1. Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.
    Yuan YH; Wang HY; Lai Y; Zhong W; Liang WL; Yan FD; Yu Z; Chen JK; Lin Y
    Cell Commun Signal; 2019 Jan; 17(1):9. PubMed ID: 30683109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation.
    Cao YM; Gu J; Zhang YS; Wei WJ; Qu N; Wen D; Liao T; Shi RL; Zhang L; Ji QH; Wang Y; Sun GH; Zhao YX; Wang YJ; Yu J; Zhu YX
    Oncol Rep; 2018 Jan; 39(1):338-348. PubMed ID: 29115628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PON1 hypermethylation is associated with progression of renal cell carcinoma.
    Li X; Yu Q
    J Cell Mol Med; 2019 Oct; 23(10):6646-6657. PubMed ID: 31400051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma.
    Guo Y; Peng Y; Gao D; Zhang M; Yang W; Linghu E; Herman JG; Fuks F; Dong G; Guo M
    Clin Epigenetics; 2017; 9():116. PubMed ID: 29075359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer.
    Liu Z; Zhu J; Cao H; Ren H; Fang X
    Int J Oncol; 2012 May; 40(5):1553-60. PubMed ID: 22293682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma.
    Yang H; Zhou J; Mi J; Ma K; Fan Y; Ning J; Wang C; Wei X; Zhao H; Li E
    Oncol Rep; 2015 Oct; 34(4):1681-91. PubMed ID: 26260613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-10b promotes nucleus pulposus cell proliferation through RhoC-Akt pathway by targeting HOXD10 in intervetebral disc degeneration.
    Yu X; Li Z; Shen J; Wu WK; Liang J; Weng X; Qiu G
    PLoS One; 2013; 8(12):e83080. PubMed ID: 24376640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of PIK3CG, a catalytic subunit of phosphatidylinositol 3-OH kinase, by CpG hypermethylation in human colorectal carcinoma.
    Semba S; Itoh N; Ito M; Youssef EM; Harada M; Moriya T; Kimura W; Yamakawa M
    Clin Cancer Res; 2002 Dec; 8(12):3824-31. PubMed ID: 12473596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
    Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
    J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
    Zhang J; Liu S; Zhang D; Ma Z; Sun L
    J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of Rab39a promotes epithelial to mesenchymal transition of cervical cancer through AKT signaling.
    Zou C; Fan J; He M; Xu Y; Wang K; Cai Y; Li M
    Exp Cell Res; 2019 May; 378(2):139-148. PubMed ID: 30826396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis.
    Wang L; Chen S; Xue M; Zhong J; Wang X; Gan L; Lam EK; Liu X; Zhang J; Zhou T; Yu J; Jin H; Si J
    Mol Med; 2012 May; 18(1):389-400. PubMed ID: 22160393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTSS1 hypermethylation is associated with prostate cancer progression.
    Chen J; Huang L; Zhu Q; Wang Z; Tang Z
    J Cell Physiol; 2020 Mar; 235(3):2687-2697. PubMed ID: 31541465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
    Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
    J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
    World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of 5-Aza-dC on 5-Fu chemosensitivity by modulating TIP30 gene expression in human colorectal cancer cells].
    Chen XB; Chen BB; Li J; Wang XF; Ma YJ; Luo SX; Lü HF
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):824-7. PubMed ID: 24447479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer.
    Shao B; Feng Y; Zhang H; Yu F; Li Q; Tan C; Xu H; Ying J; Li L; Yang D; Peng W; Tang J; Li S; Ren G; Tao Q; Xiang T
    J Cell Mol Med; 2018 Feb; 22(2):1257-1271. PubMed ID: 29193730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of microRNA-92b-3p suppresses proliferation, migration, and invasion of gastric cancer SGC-7901 cells by targeting Homeobox D10.
    Li C; Huo B; Wang Y; Cheng C
    J Cell Biochem; 2019 Oct; 120(10):17405-17412. PubMed ID: 31106881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer.
    Wang YY; Li L; Ye ZY; Zhao ZS; Yan ZL
    World J Surg Oncol; 2015 Aug; 13():259. PubMed ID: 26311318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway.
    Sun HW; Tong SL; He J; Wang Q; Zou L; Ma SJ; Tan HY; Luo JF; Wu HX
    World J Gastroenterol; 2007 Jul; 13(25):3517-22. PubMed ID: 17659701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.